Lexpos News

/Lexpos News

Five SSPs further extended

The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for 5 SSPs. The following HRT SSPs were due to expire 13 January 2023 but have been further extended to Friday 27 January 2023. SSP Expiry Date Supporting Information SSP029 Sandrena®  0.5mg and 1mg gel sachets – [...]

The post Five SSPs further extended appeared first on PSNC Website.

By |January 13th, 2023|Lexpos News|Comments Off on Five SSPs further extended

Data Security & Protection Toolkit: 2023 PSNC guidance available

PSNC has published new guidance to help community pharmacy contractors to complete the 2022/23 Data Security and Protection Toolkit. The Toolkit is used to make a pharmacy’s information governance (IG) declaration and must be completed by Friday 30th June 2023. We recommend that contractors complete the Toolkit as soon as possible. We collaborated with NHS Digital to [...]

The post Data Security & Protection Toolkit: 2023 PSNC guidance available appeared first on PSNC Website.

By |January 13th, 2023|Lexpos News|Comments Off on Data Security & Protection Toolkit: 2023 PSNC guidance available

Expiry of Lenzetto® 1.53mg/dose transdermal spray SSPs

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Lenzetto® 1.53mg/dose transdermal spray is now available to meet normal demand. As a result the following  Serious Shortage Protocols, will expire at 23.59pm on Friday 13 January 2023. After this date, any prescriptions for Lenzetto® 1.53mg/dose transdermal spray must be dispensed [...]

The post Expiry of Lenzetto® 1.53mg/dose transdermal spray SSPs appeared first on PSNC Website.

By |January 13th, 2023|Lexpos News|Comments Off on Expiry of Lenzetto® 1.53mg/dose transdermal spray SSPs

Company led medicines recall: Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for Injection Mawdsley-Brooks & Company Limited

CLMR number: CLMR (23)A/01 Date issued: 12th January 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company-led medicines recall for: Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for Injection (Mawdsley-Brooks & Company Limited). Fluphenazin-neuraxpharm® D 100 mg/ml Solution for Injection [unlicensed medicine] Batch number Expiry Date Pack Size First Distributed 200686 [...]

The post Company led medicines recall: Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for Injection Mawdsley-Brooks & Company Limited appeared first on PSNC Website.

By |January 13th, 2023|Lexpos News|Comments Off on Company led medicines recall: Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for Injection Mawdsley-Brooks & Company Limited

Minister comments on additional funding plea for pharmacy

In a statement to the House of Lords on Tuesday, Lord Markham, a Health Minister, talked about a ‘plan of using [pharmacies] more for patients [that] will put more funding their way’. He also went on to praise the sector saying they are a ‘crucial part of the front line’. This was in response to [...]

The post Minister comments on additional funding plea for pharmacy appeared first on PSNC Website.

By |January 12th, 2023|Lexpos News|Comments Off on Minister comments on additional funding plea for pharmacy